Cardiocentro Ticino

Cardiocentro Ticino is a specialized cardiovascular hospital and research center located in Lugano, Switzerland. Following its integration into the Ente Ospedaliero Cantonale (EOC) in 2021, it operates as a university-affiliated institute focusing on cardiology, cardiac surgery, and anesthesia. The center is globally recognized for its work in regenerative medicine, particularly through its dedicated Cell Therapy Unit which develops advanced therapy medicinal products (ATMPs). Beyond clinical care, the institute maintains a robust research pipeline focused on cardiac repair and cardiovascular health. It serves as a primary hub for medical education and clinical trials in the Southern Swiss region.